These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35773976)

  • 21. Expression Study and Clinical Correlations of MYC and CCAT2 in Breast Cancer Patients.
    Sarrafzadeh Sh; Geranpayeh L; Tasharrofi B; Soudyab M; Nikpayam E; Iranpour M; Mirfakhraie R; Gharesouran J; Ghafouri-Fard S; Ghafouri-Fard S
    Iran Biomed J; 2017 Sep; 21(5):303-11. PubMed ID: 28480695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calprotectin (S100A8/S100A9)-induced cytotoxicity and apoptosis in human gastric cancer AGS cells: Alteration in expression levels of Bax, Bcl-2, and ERK2.
    Shabani F; Mahdavi M; Imani M; Hosseinpour-Feizi MA; Gheibi N
    Hum Exp Toxicol; 2020 Aug; 39(8):1031-1045. PubMed ID: 32167384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of silencing colon cancer-associated transcript 2 on the proliferation, apoptosis and autophagy of gastric cancer BGC-823 cells.
    Yu ZY; Wang Z; Lee KY; Yuan P; Ding J
    Oncol Lett; 2018 Mar; 15(3):3127-3132. PubMed ID: 29435046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma.
    Zhang X; Xu Y; He C; Guo X; Zhang J; He C; Zhang L; Kong M; Chen B; Zhu C
    J Surg Oncol; 2015 Jun; 111(7):834-9. PubMed ID: 25919911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19.
    Liu G; Xiang T; Wu QF; Wang WX
    Oncol Lett; 2016 Dec; 12(6):5156-5162. PubMed ID: 28105222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the
    Yang C; Li F; Zhou W; Huang J
    J Int Med Res; 2021 May; 49(5):3000605211019938. PubMed ID: 34057837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
    Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
    Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2.
    Wang L; Zhou S; Guo B
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate-PEG/Hyd-curcumin/C18-g-PSI micelles for site specific delivery of curcumin to colon cancer cells via Wnt/β-catenin signaling pathway.
    Le TT; Kim D
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():464-471. PubMed ID: 31029341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma.
    Cai Y; Li X; Shen P; Zhang D
    Biol Res; 2018 Jan; 51(1):1. PubMed ID: 29298720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of insulin as a growth promoter in regulating the response of curcumin in human primary gingival fibroblasts: An in vitro study.
    Dixit J; Verma U; Karamjeet ; Sharma R; Balapure AK
    J Indian Soc Periodontol; 2009 Sep; 13(3):133-7. PubMed ID: 20379410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis.
    Thean LF; Blöcker C; Li HH; Lo M; Wong M; Tang CL; Tan EKW; Rozen SG; Cheah PY
    Sci Rep; 2021 Jan; 11(1):404. PubMed ID: 33432117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oncogenic lncRNA, GLCC1, promotes tumorigenesis in gastric carcinoma by enhancing the c-Myc/IGF2BP1 interaction.
    Yang DL; Dong LF; Qiu YB; Luo GY
    Neoplasma; 2021 Sep; 68(5):1052-1062. PubMed ID: 34196212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CCAT2 promotes proliferation and suppresses apoptosis of colorectal cancer cells.
    Gao P; Sun D; Guo H; Wu Z; Chen J
    J BUON; 2020; 25(4):1840-1846. PubMed ID: 33099922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active Compounds from
    Lesmana R; Susianti ; Pediatama T; Sylviana N; Susanti Pratiwi Y; Goenawan H; Supratman U
    Pak J Biol Sci; 2021 Jan; 24(1):35-41. PubMed ID: 33683029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion.
    Yan L; Wu X; Yin X; Du F; Liu Y; Ding X
    J Cell Mol Med; 2018 May; 22(5):2592-2599. PubMed ID: 29502343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin Derivative C086 Combined with Cisplatin Inhibits Proliferation of Osteosarcoma Cells.
    Jiang X; Huang Y
    Med Sci Monit; 2020 Jul; 26():e924507. PubMed ID: 32734935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
    Ruan R; Zhao XL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics analysis and identification of upregulated tumor suppressor genes associated with suppressing colon cancer progression by curcumin treatment.
    Wu D; Fu Z; Liu W; Zhao Y; Li W; Liu Q; Liang Y
    Front Pharmacol; 2023; 14():1218046. PubMed ID: 37731740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.